Skip to main content
. 2020 Nov 29;12(12):3569. doi: 10.3390/cancers12123569

Figure 5.

Figure 5

Progression-free survival (PFS) of patients undergoing mSRS as upfront (red) and adjuvant (blue) treatment. Log-rank (Mantel–Cox) test p = 0.08.